Sectoral Asset Management
Institutional investorMontreal · Series A–Late Stage · 9 people tracked
Find your way into Sectoral Asset Management
3,423 people in our graph share verified history with the Sectoral Asset Management team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Sectoral's venture arm invests in innovative healthcare companies through its late-stage NEMO family of funds, active since 2008 across North America and Europe. A newer fund, Fonds Medtech Ventures (2023), targets Canadian medtech companies. The team supports portfolio companies with capital and operational expertise to help bring new therapeutics and medical devices to patients worldwide. Its philosophy holds that strong financial returns can align with lasting societal benefits through improved health and well-being.
Source: firm website, verified Sep 1, 2026.
Team · 9 people
from curated & public directories
What they invest in
from 11 of 11 portfolio companiesHealthtech ×9Medical Devices ×7Biotech ×6Hardware ×3Digital Health ×2Wellness & Fitness ×1
HQs:United States×10
Investments · 11 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 12023 · 12022 · 12018 · 17 dated
Apnimed develops investigational oral pharmaceutical therapies for obstructive sleep apnea (OSA), including its lead clinical candidate AD109, a neuromuscular approach intended to treat undertreated and untreated OSA patients.
BiotechDigital HealthHealthtechCambridge, US
Lawrence G. Miller(Executive Officer, Director)inDennis Molnar(Executive Officer)inBarry Wohl(Chief Business Officer)inKetan Mehta(Head of Product and Engineering, Connected Wearables)Ron Farquhar(Director)Gerald Chan(Director)
Co-investorsAlpha Wave GlobalHEALTHCARE ROYALTY PARTNERSMorningside Group
Contineum is a biopharmaceutical company developing small molecule drug candidates to treat inflammatory and fibrotic diseases by modulating critical disease pathways.
BiotechHealthtech
Carmine Stengone(President and Chief Executive Officer)in
Co-investorsHadean VenturesRed Tree VentureSamsara BioCapitalCasdin CapitalFranklin Templeton
BiotechSan Leandro, US
Steve Abella(Chief Medical Officer)inGraeme Currie(Chief Operating Officer)inStephen W. Lau(President, Chief Executive Officer, and Treasurer)inKenneth Schwartz(Executive Officer)inEric Yuen(Executive Officer)inMarten Steen(Director)
Co-investorsHealthCapInkefSofinnova VenturesYsios Capital
CurvaFix develops the CurvaFix Low Profile intramedullary nailing system, curved implants for surgical stabilization of pelvic fractures.
HardwareHealthtechMedical DevicesBellevue, US
Jeffrey Poole(Executive Officer)Mark Foster(Executive Officer, Director)inSteven Dimmer(Executive Officer, Director, Promoter)Dong-Gun Kim(Director)
BoardEric Fritz(Director)inJack Tanaka(Director)in
Co-investorsAlliance of AngelsRockies Venture ClubSPRINGROCK VENTURESSwan Venture FundKeiretsu CapitalMVM Life Science Partners+1 more
HealthtechChicago, US
Tyler Wanke(Director)Leonidas Carayannopoulos(Executive Officer, Director)Christopher Wilson(Executive Officer, Director)John Slump(Executive Officer)K.C. Hoos(Executive Officer, Director)
BoardMichael Sjostrom(Director)
LENZ Therapeutics is a pharmaceutical company developing and commercializing VIZZ™, an FDA-approved aceclidine-based eye drop for treating presbyopia, a vision condition affecting over 128 million people in the US.
BiotechHealthtechMedical DevicesSan Diego, US
James McCollum(Co-founder, Board Member)Eef SchimmelpenninkinEvert Schimmelpennink(President and CEO)
Co-investorsAlpha Wave GlobalRA CapitalRaptor GroupRTW Investments L.P.Versant Ventures
Magnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems.
HardwareHealthtechMedical DevicesSeattle, US
Gregory J Bullington(Executive Officer, Director)Richard Patton(Co-founder)
BoardPaul Meister(Director)
Co-investorsEvidity Health CapitalLauder PartnersRhapsody Venture PartnersVivo CapitalHealthQuest CapitalJanus Henderson Investors+2 more
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+5 more
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)
BoardChau Khuong(Director)Allan May(Director)Mudit Jain(Director)Tracy Pappas(Director)
Co-investorsAngelini VenturesBlue Venture FundsOrbiMedTreo Ventures, LlcZühlke VenturesBridge Bank+1 more
Route 92 Medical develops medical devices and procedural solutions for patients undergoing neurovascular intervention.
BiotechHealthtechMedical DevicesSan Francisco, US
Dr. Chou(Founder, Chief Executive Officer)Dr. Joey English(Chief Medical Officer)
Co-investorsNovo HoldingsThe Vertical GroupUS Venture PartnersNorwest Venture PartnersU.S. Venture Partners
Shockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists.
HardwareHealthtechMedical DevicesFremont, US
Daniel Hawkins(Executive Officer, Director)inTodd J. Brinton(Director)inIsaac(President)
BoardJay Watkins(Director)inAntoine Papiernik(Director)inFrederic H. Moll(Director)
Co-investorsSofinnova PartnersSonder CapitalVenrock
Exits · 2
IPOs and acquisitions across the tracked portfolioApnimedNASDAQ: APMDContineum TherapeuticsNASDAQ: CTNM
Portfolio news
latest coverage across their companies
Contineum Therapeutics · stocktitan.net · Aug 25, 2026
Apnimed · bloomberg.com · Jul 31, 2026
Route 92 · finance.yahoo.com · Apr 8, 2026
Noctrix Health · nasdaqprivatemarket.com · Apr 3, 2026
Magnolia Medical Technologies · nasdaqprivatemarket.com · Oct 21, 2025
Neuros Medical · finance.yahoo.com · Jul 10, 2025
EDGe Surgical · finsmes.com · May 13, 2025
Frequently asked questions
- What stage does Sectoral Asset Management invest at?
- Sectoral Asset Management invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does Sectoral Asset Management focus on?
- Sectoral Asset Management focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sectoral Asset Management located?
- Sectoral Asset Management is headquartered in Montreal, CA.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.